Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Mar 9, 2026 · Filed Mar 10, 2026
The boss of Cytokinetics sold $482K of Cytokinetics shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$481,570
Shares × reported transaction price
13 days after results of Feb 24, 2026, 57 days before results of May 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.3% | −2.2% | −0.1% |
| 30 days | +2.2% | +0.5% | +1.7% |
| 90 days | +7.6% | +9.0% | −1.4% |
| 180 days | +18.4% | +13.3% | +5.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$228K of Cytokinetics
Automatic saleDerivative exercise or conversion — not an open-market buy.